ARTICLE | Clinical News
Antisense compounds regulatory update
March 13, 2000 8:00 AM UTC
ISIP said it has received 20 U.S. patents covering antisense inhibitors of inflammatory responses, signal transduction, apoptosis, drug resistance and cancer. ...